BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 30005473)

  • 1. The value of chrtmogenic activity assay in diagnosis and therapeitic monitoring of hemophlia.
    Adcock DM; Tiefenbacher S; Pruthi RK
    MLO Med Lab Obs; 2017 Feb; 49(2):8, 10, 12-4. PubMed ID: 30005473
    [No Abstract]   [Full Text] [Related]  

  • 2. Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1.
    Girolami A; Dal Bo Zanon R; Procidano M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):863-71. PubMed ID: 6176512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogenic Factor VIII Assays for Improved Diagnosis of Hemophilia A.
    Rodgers S; Duncan E
    Methods Mol Biol; 2017; 1646():265-276. PubMed ID: 28804835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new APTT assay employing a chromogenic substrate and a centrifugal autoanalyzer.
    Yamada K; Meguro T
    Thromb Res; 1979; 15(3-4):351-8. PubMed ID: 158846
    [No Abstract]   [Full Text] [Related]  

  • 5. Towards standardization of clot waveform analysis and recommendations for its clinical applications.
    Shima M; Thachil J; Nair SC; Srivastava A;
    J Thromb Haemost; 2013 Jul; 11(7):1417-20. PubMed ID: 23648068
    [No Abstract]   [Full Text] [Related]  

  • 6. Discrepancies between the one-stage clotting assay and the chromogenic assay in haemophilia B.
    Kihlberg K; Strandberg K; Rosén S; Ljung R; Astermark J
    Haemophilia; 2017 Jul; 23(4):620-627. PubMed ID: 28440032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacotherapy of hemophilia with the preparation of Lagochilus inebrians BGE].
    Akopow IE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(1):72-83. PubMed ID: 4104085
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood platelets of hemophilia patients].
    Weibbbach G; Bührdel P; Domula M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(1):131-43. PubMed ID: 4128511
    [No Abstract]   [Full Text] [Related]  

  • 9. New developments in laboratory diagnosis and monitoring.
    Kitchen S; Hayward C; Negrier C; Dargaud Y
    Haemophilia; 2010 Jul; 16 Suppl 5():61-6. PubMed ID: 20590858
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of hemophilia and Willebrand-Jürgens syndrome. 2. Results of studies in hemophilia patients and hemophilia carriers].
    Lutze G; Schlote A; Beyer H; Kropf S
    Z Gesamte Inn Med; 1985 Aug; 40(16):479-83. PubMed ID: 4060793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring of modified factor VIII and IX products.
    Kitchen S; Gray E; Mertens K
    Haemophilia; 2014 May; 20 Suppl 4():36-42. PubMed ID: 24762273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovations in coagulation: improved options for treatment of hemophilia A and B.
    Pabinger-Fasching I; Pipe S
    Thromb Res; 2013 Mar; 131 Suppl 2():S1. PubMed ID: 23537720
    [No Abstract]   [Full Text] [Related]  

  • 13. Bleeding time after aspirin in disorders of intrinsic clotting.
    Kaneshiro MM; Mielke CH; Kasper CK; Rapaport SI
    N Engl J Med; 1969 Nov; 281(19):1039-42. PubMed ID: 5307310
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thromboplastin generation test and possible errors in its reproducibility].
    Tarasova LN
    Lab Delo; 1980; (11):669-71. PubMed ID: 6160299
    [No Abstract]   [Full Text] [Related]  

  • 15. Modification of the Bethesda assay for factor VIII or IX inhibitors to improve efficiency.
    Gadarowski JJ; Czapek EE; Ontiveros JD; Pedraza JL
    Acta Haematol; 1988; 80(3):134-8. PubMed ID: 3143212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemophilia and Christmas disease (a clinical and haematological study).
    Dube B; Chawla SC; Gupta SP; Agarwal SP; Dikshit SK; Khanna MN; Srivastava AB; Srivastava TP; Mishra RM
    J Assoc Physicians India; 1972 Jan; 20(1):47-54. PubMed ID: 5025985
    [No Abstract]   [Full Text] [Related]  

  • 17. Response of factor VIII and IX-deficient blood to wild type and high membrane affinity mutant factor VIIa in an in vitro whole blood clotting assay: possible correlation to clinical outcome.
    Henderson N; Key NS; Christie B; Kisiel W; Foster D; Nelsestuen GL
    Thromb Haemost; 2002 Jul; 88(1):98-103. PubMed ID: 12152685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated amidolytic method for evaluating the activated partial thromboplastin time compared with a conventional coagulation method.
    Tripodi A; Poggio M; Scapellato L; Mannucci PM
    Haemostasis; 1989; 19(4):205-12. PubMed ID: 2509308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dentition restoration in hemophilia under substitution of AHG concentrates].
    Tetsch P; Esser E
    Dtsch Zahnarztl Z; 1972 May; 27(5):399-404. PubMed ID: 4112700
    [No Abstract]   [Full Text] [Related]  

  • 20. Problems involved in grading the severity of hemophilia by test results.
    Kaneda T; Nagayama M; Minato F; Nakahira H; Nakajima J; Shikimori M
    J Oral Surg; 1978 Dec; 36(12):956-9. PubMed ID: 309932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.